Africa News of Saturday, 28 February 2026Source: the-star.co.keThe Global Fund has committed an additional Sh256 million ($2 million) to support Kenya’s rollout of the long-acting HIV prevention injection, Lenacapavir. Kenya received 21,000 doses early this month, financed by the Fund for Sh370 million ($2.9 million). Global Fund senior portfolio manager Paul Maccarrick described the moment as historic. “In the spirit of continuing commitment, Global Fund has directly invested $2.9 million (about Sh370 million) for this initial procurement of the product being launched here today, and a further $2.0 million (about Sh256 million) for programme implementation rollout to ensure access by targeted beneficiaries,” Maccarrick said. The Global Fund has been a major financier of Kenya’s HIV response for more than two decades.

Source: The Star February 28, 2026 07:25 UTC